Liaoning Xinde New Material Technology Valuation

Q: What is the Fair Price of 301349 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

301349 (CN¥30.68) is trading above our estimate of [[fair value]] (CN¥5.56)

Is 301349 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 301349 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 301349 (CN¥30.68) is trading above our estimate of fair value (CN¥5.56)

Significantly Below Fair Value: 301349 is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 301349?

Key metric: As 301349 is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for 301349. This is calculated by dividing 301349's market cap by their current revenue.
What is 301349's PS Ratio?
PS Ratio	3.8x
Sales	CN¥812.77m
Market Cap	CN¥3.10b

301349 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	2.1x
Enterprise Value/EBITDA	-55.8x
PEG Ratio	n/a

Price to Sales Ratio vs Peers

How does 301349's PS Ratio compare to its peers?

The above table shows the PS ratio for 301349 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PS	Estimated Growth	Market Cap
Peer Average	3.3x
300239 Baotou Dongbao Bio-TechLtd	3.9x	n/a	CN¥3.4b
688089 Cabio Biotech (Wuhan)	7.1x	22.4%	CN¥3.6b
002054 Dymatic ChemicalsInc	1x	n/a	CN¥3.0b
688133 Shanghai Titan Scientific	1.3x	12.2%	CN¥3.8b
301349 Liaoning Xinde New Material Technology	3.8x	30.7%	CN¥3.1b

Price-To-Sales vs Peers: 301349 is expensive based on its Price-To-Sales Ratio (3.8x) compared to the peer average (3.3x).

Price to Sales Ratio vs Industry

How does 301349's PS Ratio compare vs other companies in the CN Chemicals Industry?

24 Companies	Price / Sales	Estimated Growth	Market Cap
600346 Hengli PetrochemicalLtd	0.4x	4.3%	US$13.80b
002493 Rongsheng Petrochemical	0.3x	8.5%	US$12.60b
000301 Jiangsu Eastern ShenghongLtd	0.4x	6.8%	US$8.54b
601233 Tongkun Group	0.3x	4.6%	US$3.76b

24 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Sales vs Industry: 301349 is expensive based on its Price-To-Sales Ratio (3.8x) compared to the CN Chemicals industry average (2.4x).

Price to Sales Ratio vs Fair Ratio

What is 301349's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

301349 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio	3.8x
Fair PS Ratio	1.6x

Price-To-Sales vs Fair Ratio: 301349 is expensive based on its Price-To-Sales Ratio (3.8x) compared to the estimated Fair Price-To-Sales Ratio (1.6x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 301349 forecast and predictions for the stock price in 12 month’s time.
Date	Share Price	Average 1Y Price Target	Dispersion	High	Low	1Y Actual price	Analysts
Current	CN¥30.68	CN¥36.39 +18.6%	9.9%	CN¥40.01	CN¥32.77	n/a	2
Nov ’25	CN¥27.20	CN¥36.39 +33.8%	9.9%	CN¥40.01	CN¥32.77	n/a	2
Oct ’25	CN¥29.95	CN¥31.54 +5.3%	26.9%	CN¥40.01	CN¥23.07	n/a	2
Sep ’25	CN¥23.08	CN¥31.54 +36.7%	26.9%	CN¥40.01	CN¥23.07	n/a	2
Aug ’25	CN¥25.53	CN¥37.17 +45.6%	7.6%	CN¥40.01	CN¥34.33	n/a	2
Jul ’25	CN¥28.16	CN¥42.45 +50.7%	18.4%	CN¥53.00	CN¥34.33	n/a	3
Jun ’25	CN¥32.11	CN¥43.67 +36.0%	21.4%	CN¥53.00	CN¥34.33	n/a	2
May ’25	CN¥32.06	CN¥43.67 +36.2%	21.4%	CN¥53.00	CN¥34.33	n/a	2
Apr ’25	CN¥36.85	CN¥48.52 +31.7%	9.2%	CN¥53.00	CN¥44.03	n/a	2
Mar ’25	CN¥30.88	CN¥48.52 +57.1%	9.2%	CN¥53.00	CN¥44.03	n/a	2
Feb ’25	CN¥29.47	CN¥48.52 +64.6%	9.2%	CN¥53.00	CN¥44.03	n/a	2
Jan ’25	CN¥47.08	CN¥48.52 +3.0%	9.2%	CN¥53.00	CN¥44.03	n/a	2
Dec ’24	CN¥48.62	CN¥48.52 -0.2%	9.2%	CN¥53.00	CN¥44.03	n/a	2

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

Western MiningLtd

CN¥39.7b

Engages in the mining, smelting, and trading of metals in Mainland China and internationally.

601168

CN¥16.65

-5.1%

29.9%

MeiHua Holdings GroupLtd

CN¥28.7b

A synthetic biology company, provides amino acid nutrition and health solutions in China and internationally.

600873

CN¥10.06

-6.3%

5.3%

Yunnan Yuntianhua

CN¥39.6b

Engages in the phosphate ore mining, chemical fertilizers, engineering materials, agriculture, and trade and logistics businesses in China.

600096

CN¥21.72

-5.6%

38.2%